Vermont’s governor has signed S. 48, a law that would revise the state’s current pharmaceutical marketing disclosure requirements. The new statute expands the application of Vermont’s current requirement that pharmaceutical manufacturers annually disclose certain expenditures made in connection to interactions with Vermont health care professionals. Under the revised law, the disclosure requirement now also applies to medical device companies. Further, the revised law adds a ban on certain items and expenditures that was not included in the previous version. Notably, this gift ban may go into effect as early as July 1, 2009. The following summarizes the revised Vermont law, including key dates for compliance.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact email@example.comRegister
Vermont enacts revised HCP disclosure requirements, gift ban
To view this article you need a PDF viewer such as Adobe Reader.
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email firstname.lastname@example.org.
Related topic hubs
“I have found the articles in Lexology/Newsstand to be closely related to the topics I am interested in. The selection feature during registration helps in increasing the relevance of the content of the emails. They’re easy to understand and I appreciate that they are only as long as necessary to cover the essentials. I would recommend it to other attorneys.”